FDA Promises CBD Hearings in April, But They’re Just the First Step
Authored By Peter Becker March 5, 2019 POSTED IN REGULATORY While the 2018 Farm Bill removed hemp from the Drug Enforcement Administration’s regulatory oversight, the Food and Drug Administration (FDA) continues to oversee foods, drugs or cosmetics that contain hemp...
Further Consideration of the STATES Act
If you wish to re-publish this story please do so with following accreditation AUTHOR: “Jordan Zoot. “aBIZinaBOX Inc., CPA’s” PUBLISHER: CANNABIS LAW REPORT Numerous attempts to introduce legislation to relax the provisions that placed cannabis on Schedule I of the...
Pennsylvania Medical Marijuana: Transparent Cannabis
Authored By: William F. McDevitt, Esq. The Pennsylvania Commonwealth Court has decided a new case that may have a huge impact on cannabis licensing in the Mid-Atlantic region. The Commonwealth Court hears cases involving state and local government entities and state...
The Role of Kovel Accountants in California’s Regulated Cannabis Industry
Authored By: Jordan Zoot We are rapidly approaching the close of 2018 and the first birthday of a regulated medical and adult-use cannabis industry in California. The transformation from a lightly regulated medical cannabis industry to a highly regulated medical and...
WHO Expert Committee on Drug Dependence Closed Door Sessions May Result In International Cannabis Re-Scheduling
Authored By: Mark Taylor Global health experts are preparing to formally raise no objections for wider medicinal use of marijuana following groundbreaking talks in Geneva, as calls grow for the creation of a pan-European marijuana lobby group to help shape and...Top 200 Cannabis Lawyers
We Support